These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 18303060)

  • 1. Reducing patient risk for human papillomavirus infection and cervical cancer.
    Herbert J; Coffin J
    J Am Osteopath Assoc; 2008 Feb; 108(2):65-70. PubMed ID: 18303060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology of human papillomavirus infection and cervical cancer and future perspectives in Hong Kong, Singapore and Taiwan.
    Tay SK; Ngan HY; Chu TY; Cheung AN; Tay EH
    Vaccine; 2008 Aug; 26 Suppl 12():M60-70. PubMed ID: 18945415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human papillomavirus, cervical cancer, and the vaccines.
    Tovar JM; Bazaldua OV; Vargas L; Reile E
    Postgrad Med; 2008 Jul; 120(2):79-84. PubMed ID: 18654072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human papillomavirus infection and cervical cancer prevention in Japan and Korea.
    Konno R; Shin HR; Kim YT; Song YS; Sasagawa T; Inoue M; Park JS
    Vaccine; 2008 Aug; 26 Suppl 12():M30-42. PubMed ID: 18945412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology and prevention of cervical cancer in Indonesia, Malaysia, the Philippines, Thailand and Vietnam.
    Domingo EJ; Noviani R; Noor MR; Ngelangel CA; Limpaphayom KK; Thuan TV; Louie KS; Quinn MA
    Vaccine; 2008 Aug; 26 Suppl 12():M71-9. PubMed ID: 18945416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papillomavirus and cervical cancer in Australasia and Oceania: risk-factors, epidemiology and prevention.
    Garland SM; Brotherton JM; Skinner SR; Pitts M; Saville M; Mola G; Jones RW
    Vaccine; 2008 Aug; 26 Suppl 12():M80-8. PubMed ID: 18945417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ano-genital papillomavirus infections in women].
    Riethmuller D
    Rev Prat; 2006 Nov; 56(17):1893-900. PubMed ID: 17243387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human papillomavirus infection and cervical cancer prevention in India, Bangladesh, Sri Lanka and Nepal.
    Sankaranarayanan R; Bhatla N; Gravitt PE; Basu P; Esmy PO; Ashrafunnessa KS; Ariyaratne Y; Shah A; Nene BM
    Vaccine; 2008 Aug; 26 Suppl 12():M43-52. PubMed ID: 18945413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preventive and therapeutic HPV vaccines.
    Monie A; Hung CF; Wu TC
    Curr Opin Investig Drugs; 2007 Dec; 8(12):1038-50. PubMed ID: 18058574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Vaccination against human papillomavirus. Implementation and efficacy against cervical cancer control].
    Bégué P; Henrion R; Blanc B; Girard M; Sancho-Garnier H
    Bull Acad Natl Med; 2007 Dec; 191(9):1805-16; discussion 1816-7. PubMed ID: 18663976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of cross-protection against oncogenic HPV by an HPV-16/18 AS04-adjuvanted cervical cancer vaccine: importance of virological and clinical endpoints and implications for mass vaccination in cervical cancer prevention.
    Jenkins D
    Gynecol Oncol; 2008 Sep; 110(3 Suppl 1):S18-25. PubMed ID: 18653221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in primary and secondary interventions for cervical cancer: human papillomavirus prophylactic vaccines and testing.
    Wheeler CM
    Nat Clin Pract Oncol; 2007 Apr; 4(4):224-35. PubMed ID: 17392713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevaccination distribution of human papillomavirus types in women attending at cervical cancer screening in Belgium.
    Arbyn M; Benoy I; Simoens C; Bogers J; Beutels P; Depuydt C
    Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):321-30. PubMed ID: 19124515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus and the HPV vaccine: are the benefits worth the risks?
    Knudtson M; Tiso S; Phillips S
    Nurs Clin North Am; 2009 Sep; 44(3):293-9. PubMed ID: 19683091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genital human papillomavirus infection.
    Dunne EF; Markowitz LE
    Clin Infect Dis; 2006 Sep; 43(5):624-9. PubMed ID: 16886157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New advances in vaccine technology and improved cervical cancer prevention.
    Huh WK; Kendrick JE; Alvarez RD
    Obstet Gynecol; 2007 May; 109(5):1187-92. PubMed ID: 17470604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. General practitioners' perception of risk factors for cervical cancer development: consequences for patient education.
    Baay MF; Verhoeven V; Peremans L; Avonts D; Vermorken JB
    Patient Educ Couns; 2006 Aug; 62(2):277-81. PubMed ID: 16533588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cervical cancer screening: from the Papanicolaou smear to the vaccine era.
    Crum CP; Abbott DW; Quade BJ
    J Clin Oncol; 2003 May; 21(10 Suppl):224s-230s. PubMed ID: 12743139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [HPV-infection].
    Schmidt-Petruschkat S
    MMW Fortschr Med; 2007 Mar; 149(12):29-31. PubMed ID: 17674887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human papillomavirus (HPV) infection, cervical cancer and vaccination against HPV: a Nordic perspective.
    Kjaer SK
    Acta Obstet Gynecol Scand; 2007; 86(11):1286-9. PubMed ID: 17963055
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.